Thorsten Ecke

Wound Dressings and Comparative Effectiveness Data

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study

Cancer statistics, 2024

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

Widespread Protein Aggregation as an Inherent Part of Aging in C. elegans

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Modern modeling techniques had limited external validity in predicting mortality from traumatic brain injury

When mutants gain new powers: news from the mutant p53 field

PLGA-based nanoparticles: An overview of biomedical applications

Systematic Review of Complications of Prostate Biopsy

Epidemiology of Prostate Cancer

Hepatocellular carcinoma

Nanoparticle-mediated p53 gene therapy for tumor inhibition

Targeted therapies in bladder cancer: an overview of in vivo research

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Molecular chaperones in protein folding and proteostasis

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

Bladder cancer

Urothelial carcinoma management in elderly or unfit patients

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models

Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

Vinflunine

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010

The amyloid state and its association with protein misfolding diseases

Regulatory networks defining EMT during cancer initiation and progression

The first 30 years of p53: growing ever more complex

Molecular biology and targeted therapies for urothelial carcinoma

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma

Endoplasmic reticulum-associated SKN-1A/Nrf1 mediates a cytoplasmic unfolded protein response and promotes longevity

Breast Cancer Treatment

Natural product and natural product derived drugs in clinical trials

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation

Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses

Ultrasound Elastography: Review of Techniques and Clinical Applications

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability

Combined treatment with pazopanib and vinflunine in patients with advanced urothelial carcinoma refractory after first-line therapy

A phase II trial of temsirolimus in second-line metastatic urothelial cancer

Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine

Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer

Complications and risk factors of transrectal ultrasound guided needle biopsies of the prostate evaluated by questionnaire

Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma

External Validation of an Artificial Neural Network and Two Nomograms for Prostate Cancer Detection

Post-treatment prognostic model for patients (pts) with metastatic urothelial cancer (UC) treated with first-line chemotherapy.

TP53 gene mutations as an independent marker for urinary bladder cancer progression

Differential protein expression profiling by iTRAQ-2DLC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor KiSS-1 gene

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

TP53 gene mutations in prostate cancer progression.

Does a new ultrasound probe change the complication rates of transrectal ultrasound-guided needle biopsies of the prostate?

Repair of a vesico-vaginal fistula with amniotic membrane – Step 1 of the IDEAL recommendations of surgical innovation